Angivent MR 35mg Tablet is used to manage ischemic heart disease, angina pectoris, and squeals of infarction
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Trimetazidine (TMZ) treats conditions like angina by helping the body metabolize fatty acids and improving oxygen use. It enhances blood flow to the heart and stabilizes blood pressure, reducing chest pain from blocked vessels and improving performance in heart-related diseases. Besides angina, TMZ can treat heart failure and peripheral artery disease. It is usually taken as a pill twice daily. Inform your doctor about any medications you use before starting TMZ. Currently, no known drugs interact with TMZ.
Avoid taking TMZ if you:
Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Avoid consumption of alcohol while taking Angivent MR 35mg Tablet because it may make you dizzy.
Angivent MR 35mg Tablet is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
Angivent MR 35mg Tablet is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
Do not drive or operate any machinery if you feel dizzy after taking Angivent MR 35mg Tablet
Angivent MR 35mg Tablet is not recommended for use if you are having kidney-related problems. Consult your doctor before taking it.
Angivent MR 35mg Tablet is not recommended for use if you are having liver problems. Consult your doctor before taking it.
Angivent MR works by optimizing the metabolism of fatty acids and glucose, thereby allowing more blood flow and oxygen supply to the heart. It also reduces the thickening and scarring of heart tissue. This results in reducing chest pain due to blood vessel narrowing or blocking.
Dizziness, headache, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria, asthenia.
Trimetazidine Dihydrochloride is a 3-keto acyl CoA thiolase (KAT) inhibitor. It works by inhibiting the fatty acid pathway and enhancing the glucose pathway for energy production, which is more efficient and oxygen-conserving. This mechanism reduces the production of lactic acid, thereby alleviating angina pectoris symptoms.
No known interactions with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents, or digitalis preparations.
Hypersensitivity to Trimetazidine Dihydrochloride.
Not intended for curative treatment of angina attacks, initial treatment of unstable angina pectoris, or myocardial infarction.
Keep in a dry place away from light and heat. Keep out of the reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.